{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "22065768", "DateCompleted": {"Year": "2012", "Month": "01", "Day": "26"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "13"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1073/pnas.1114854108"], "ArticleDate": [{"Year": "2011", "Month": "11", "Day": "07"}], "Journal": {"ISSN": "1091-6490", "JournalIssue": {"Volume": "108", "Issue": "46", "PubDate": {"Year": "2011", "Month": "Nov", "Day": "15"}}, "Title": "Proceedings of the National Academy of Sciences of the United States of America", "ISOAbbreviation": "Proc Natl Acad Sci U S A"}, "ArticleTitle": "Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions.", "Pagination": {"StartPage": "18714", "EndPage": "18719", "MedlinePgn": "18714-9"}, "Abstract": {"AbstractText": ["The current gold standard for the culture of human pluripotent stem cells requires the use of a feeder layer of cells. Here, we develop a spatially defined culture system based on UV/ozone radiation modification of typical cell culture plastics to define a favorable surface environment for human pluripotent stem cell culture. Chemical and geometrical optimization of the surfaces enables control of early cell aggregation from fully dissociated cells, as predicted from a numerical model of cell migration, and results in significant increases in cell growth of undifferentiated cells. These chemically defined xeno-free substrates generate more than three times the number of cells than feeder-containing substrates per surface area. Further, reprogramming and typical gene-targeting protocols can be readily performed on these engineered surfaces. These substrates provide an attractive cell culture platform for the production of clinically relevant factor-free reprogrammed cells from patient tissue samples and facilitate the definition of standardized scale-up friendly methods for disease modeling and cell therapeutic applications."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "The Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA."}], "Identifier": [], "LastName": "Saha", "ForeName": "Krishanu", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Mei", "ForeName": "Ying", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Reisterer", "ForeName": "Colin M", "Initials": "CM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Pyzocha", "ForeName": "Neena Kenton", "Initials": "NK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yang", "ForeName": "Jing", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Muffat", "ForeName": "Julien", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Davies", "ForeName": "Martyn C", "Initials": "MC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Alexander", "ForeName": "Morgan R", "Initials": "MR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Langer", "ForeName": "Robert", "Initials": "R"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Anderson", "ForeName": "Daniel G", "Initials": "DG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jaenisch", "ForeName": "Rudolf", "Initials": "R"}], "GrantList": [{"GrantID": "R01 DE016516", "Acronym": "DE", "Agency": "NIDCR NIH HHS", "Country": "United States"}, {"GrantID": "R01-CA087869", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R01-HD045022", "Acronym": "HD", "Agency": "NICHD NIH HHS", "Country": "United States"}, {"GrantID": "R37-CA084198", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R37 CA084198", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "085246", "Acronym": "WT_", "Agency": "Wellcome Trust", "Country": "United Kingdom"}, {"GrantID": "R01 HD045022", "Acronym": "HD", "Agency": "NICHD NIH HHS", "Country": "United States"}, {"Acronym": "WT_", "Agency": "Wellcome Trust", "Country": "United Kingdom"}, {"GrantID": "DE016516", "Acronym": "DE", "Agency": "NIDCR NIH HHS", "Country": "United States"}, {"GrantID": "R01 CA087869", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Proc Natl Acad Sci U S A", "NlmUniqueID": "7505876", "ISSNLinking": "0027-8424"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biocompatible Materials"}, {"RegistryNumber": "0", "NameOfSubstance": "Polymers"}, {"RegistryNumber": "0", "NameOfSubstance": "Polystyrenes"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Biocompatible Materials"}, {"QualifierName": [], "DescriptorName": "Cell Culture Techniques"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Materials Testing"}, {"QualifierName": ["methods"], "DescriptorName": "Microscopy, Fluorescence"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ozone"}, {"QualifierName": ["cytology"], "DescriptorName": "Pluripotent Stem Cells"}, {"QualifierName": ["chemistry"], "DescriptorName": "Polymers"}, {"QualifierName": ["chemistry"], "DescriptorName": "Polystyrenes"}, {"QualifierName": [], "DescriptorName": "Surface Properties"}, {"QualifierName": ["methods"], "DescriptorName": "Tissue Engineering"}, {"QualifierName": [], "DescriptorName": "Transgenes"}, {"QualifierName": [], "DescriptorName": "Ultraviolet Rays"}], "CoiStatement": "Conflict of interest statement: R.L., R.J., and D.G.A. are advisors to Stemgent, and R.L. and R.J. are cofounders of Fate Therapeutics."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Nishikawa S-I, Goldstein RA, Nierras CR. The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol. 2008;9:725\u2013729.", "ArticleIdList": ["18698329"]}, {"Citation": "Nelson TJ, Martinez-Fernandez A, Terzic A. Induced pluripotent stem cells: Developmental biology to regenerative medicine. Nat Rev Cardiol. 2010;7:700\u2013710.", "ArticleIdList": ["20956984"]}, {"Citation": "Saha K, Jaenisch R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell. 2009;5:584\u2013595.", "ArticleIdList": ["PMC2921621", "19951687"]}, {"Citation": "Chen G, et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods. 2011;8:424\u2013429.", "ArticleIdList": ["PMC3084903", "21478862"]}, {"Citation": "Ludwig TE, et al. Feeder-independent culture of human embryonic stem cells. Nat Methods. 2006;3:637\u2013646.", "ArticleIdList": ["16862139"]}, {"Citation": "Braam SR, et al. Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin. Stem Cells. 2008;26:2257\u20132265.", "ArticleIdList": ["18599809"]}, {"Citation": "Rodin S, et al. Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol. 2010;28:611\u2013615.", "ArticleIdList": ["20512123"]}, {"Citation": "Sun N, et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci USA. 2009;106:15720\u201315725.", "ArticleIdList": ["PMC2739869", "19805220"]}, {"Citation": "Tsutsui H, et al. An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells. Nat Commun. 2011;2:167.", "ArticleIdList": ["PMC3161511", "21266967"]}, {"Citation": "Klim JR, Li L, Wrighton PJ, Piekarczyk MS, Kiessling LL. A defined glycosaminoglycan-binding substratum for human pluripotent stem cells. Nat Methods. 2010;7:989\u2013994.", "ArticleIdList": ["PMC2994976", "21076418"]}, {"Citation": "Mei Y, et al. Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater. 2010;9:768\u2013778.", "ArticleIdList": ["PMC3388774", "20729850"]}, {"Citation": "Melkoumian Z, et al. Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol. 2010;28:606\u2013610.", "ArticleIdList": ["20512120"]}, {"Citation": "Gerecht S, et al. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci USA. 2007;104:11298\u201311303.", "ArticleIdList": ["PMC2040893", "17581871"]}, {"Citation": "Villa-Diaz LG, et al. Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat Biotechnol. 2010;28:581\u2013583.", "ArticleIdList": ["PMC3471651", "20512122"]}, {"Citation": "Hockemeyer D, et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol. 2009;27:851\u2013857.", "ArticleIdList": ["PMC4142824", "19680244"]}, {"Citation": "Hockemeyer D, et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol. 2011;29:731\u2013734.", "ArticleIdList": ["PMC3152587", "21738127"]}, {"Citation": "Zwaka TP, Thomson JA. Homologous recombination in human embryonic stem cells. Nat Biotechnol. 2003;21:319\u2013321.", "ArticleIdList": ["12577066"]}, {"Citation": "Hanna JH, Saha K, Jaenisch R. Pluripotency and cellular reprogramming: Facts, hypotheses, unresolved issues. Cell. 2010;143:508\u2013525.", "ArticleIdList": ["PMC3032267", "21074044"]}, {"Citation": "Segers VFM, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008;451:937\u2013942.", "ArticleIdList": ["18288183"]}, {"Citation": "Soldner F, et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell. 2011;146:318\u2013331.", "ArticleIdList": ["PMC3155290", "21757228"]}, {"Citation": "Martin MJ, Muotri A, Gage F, Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med. 2005;11:228\u2013232.", "ArticleIdList": ["15685172"]}, {"Citation": "Ohgushi M, et al. Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell. 2010;7:225\u2013239.", "ArticleIdList": ["20682448"]}, {"Citation": "Chen G, Hou Z, Gulbranson DR, Thomson JA. Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells. Cell Stem Cell. 2010;7:240\u2013248.", "ArticleIdList": ["PMC2916864", "20682449"]}, {"Citation": "Vickerman JC, Briggs D. ToF-SIMS: Surface Analysis by Mass Spectrometry. West Sussex, UK: IM Publications, Chichester; 2001."}, {"Citation": "Yang J, et al. Polymer surface functionalities that control human embryoid body cell adhesion revealed by high throughput surface characterization of combinatorial material microarrays. Biomaterials. 2010;31:8827\u20138838.", "ArticleIdList": ["PMC2992358", "20832108"]}, {"Citation": "Mitchell SA, et al. Cellular attachment and spatial control of cells using micro-patterned ultra-violet/ozone treatment in serum enriched media. Biomaterials. 2004;25:4079\u20134086.", "ArticleIdList": ["15046899"]}, {"Citation": "Watanabe K, et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol. 2007;25:681\u2013686.", "ArticleIdList": ["17529971"]}, {"Citation": "Rowland TJ, et al. Roles of integrins in human induced pluripotent stem cell growth on Matrigel and vitronectin. Stem Cells Dev. 2010;19:1231\u20131240.", "ArticleIdList": ["19811096"]}, {"Citation": "N\u00e4rv\u00e4 E, et al. High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol. 2010;28:371\u2013377.", "ArticleIdList": ["20351689"]}, {"Citation": "Laurent LC, et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell. 2011;8:106\u2013118.", "ArticleIdList": ["PMC3043464", "21211785"]}, {"Citation": "Li L, et al. Individual cell movement, asymmetric colony expansion, rho-associated kinase, and E-cadherin impact the clonogenicity of human embryonic stem cells. Biophys J. 2010;98:2442\u20132451.", "ArticleIdList": ["PMC2877320", "20513387"]}, {"Citation": "Soldner F, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009;136:964\u2013977.", "ArticleIdList": ["PMC2787236", "19269371"]}, {"Citation": "Guilak F, et al. Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell. 2009;5:17\u201326.", "ArticleIdList": ["PMC2768283", "19570510"]}, {"Citation": "Bauwens CL, et al. Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. Stem Cells. 2008;26:2300\u20132310.", "ArticleIdList": ["18583540"]}]}], "History": [{"Year": "2011", "Month": "11", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "11", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "1", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "5", "Day": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["22065768", "PMC3219112", "10.1073/pnas.1114854108", "1114854108"]}}], "PubmedBookArticle": []}